Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 17/20 | 0.69 |
| ▸ | MMP9 | P14780 | 17/20 | 0.69 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.59 |
| ▸ | MMP8 | P22894 | 1/20 | 0.55 |
| ▸ | MMP13 | P45452 | 1/20 | 0.55 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.55 |
| ▸ | MMP1 | P03956 | 2/20 | 0.53 |
| ▸ | MMP14 | P50281 | 2/20 | 0.53 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5033356 | 1.00 | MMP2 (0.69) | MMP2MMP9ADAMTS5MMP8MMP13 | |
| Hydroxyamine SCHEMBL7688383 | 0.98 | MMP2 (0.67) | MMP2MMP9ADAMTS5MMP8MMP13 | |
| SCHEMBL7954530 | 0.94 | MMP2 (0.68) | MMP2MMP9ADAMTS5MMP8MMP13 | |
| SCHEMBL7945731 | 0.91 | MMP2 (0.57) | MMP2MMP9ADAMTS5MMP13MMP1 | |
| SCHEMBL5034658 | 0.90 | MMP2 (0.68) | MMP2MMP9ADAMTS5MMP13MMP1 | |
| SCHEMBL7952666 | 0.87 | MMP2 (0.67) | MMP2MMP9ADAMTS5MMP8MMP13 | |
| SCHEMBL7952667 | 0.87 | MMP2 (0.67) | MMP2MMP9ADAMTS5MMP8MMP13 | |
| SCHEMBL7956006 | 0.87 | MMP2 (0.64) | MMP2MMP9MMP8MMP13ADAMTS4 | |
| SCHEMBL5033750 | 0.86 | MMP2 (0.56) | MMP2MMP9ADAMTS5MMP13MMP1 | |
| SCHEMBL5031591 | 0.85 | MMP2 (0.55) | MMP2MMP9ADAMTS5MMP13MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6277987-B1 | FOR INHIBITING MATRIX-DEGRADING METALLOPROTEINASES IN MAMMALS | NOVARTIS AG (CH) | 2001-08-21 | — | — | US | disclosed |